Primary Site >> Liver Cancer

Gene >> NCR3

  • 1990
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2016
  • 2018
Ref: Detection of tumour antigens in sera of patients with hepatocellular carcinoma using monoclonal antibodies.
PMID: 1965408
Ref: Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.
PMID: 19551844
Ref: Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.
PMID: 19720422
Ref: Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells.
PMID: 21106845
Ref: [Expression and significance of the NK cell receptors in primary hepatocellular carcinoma and paracancerous tissues].
PMID: 22558993
Ref: Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.
PMID: 23225218
Ref: Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
PMID: 23801635
Ref: Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.
PMID: 26223768
Ref: Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
PMID: 27091211
Ref: The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.
PMID: 27622013
Ref: Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma.
PMID: 30153337
Ref: Globo-A Binds to the Recombinant Natural Cytotoxicity Receptor NKp44.
PMID: 30175783
Ref: Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis.
PMID: 30238080